| __timestamp | Blueprint Medicines Corporation | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7890000 | 38783000000 |
| Thursday, January 1, 2015 | 14456000 | 42585000000 |
| Friday, January 1, 2016 | 19218000 | 45702000000 |
| Sunday, January 1, 2017 | 27986000 | 46372000000 |
| Monday, January 1, 2018 | 47928000 | 46910000000 |
| Tuesday, January 1, 2019 | 96388000 | 48890000000 |
| Wednesday, January 1, 2020 | 157743000 | 50129000000 |
| Friday, January 1, 2021 | 195293000 | 54559000000 |
| Saturday, January 1, 2022 | 237374000 | 62081000000 |
| Sunday, January 1, 2023 | 295141000 | 105931000000 |
| Monday, January 1, 2024 | 359272000 | 77201000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation, two giants in the industry, showcase contrasting strategies in this domain. Over the past decade, Dr. Reddy's has consistently maintained higher SG&A expenses, peaking at approximately 106 billion in 2023, reflecting its expansive global operations. In contrast, Blueprint Medicines, a relatively newer player, has seen a steady increase in SG&A costs, rising from 7.9 million in 2014 to nearly 295 million in 2023. This 37-fold increase highlights its aggressive growth strategy. While Dr. Reddy's focuses on sustaining its market position, Blueprint Medicines is investing heavily in expansion. The data from 2014 to 2023 reveals a fascinating narrative of growth and strategic financial management, with each company navigating its unique path in the pharmaceutical landscape.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation Trends and Insights
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Blueprint Medicines Corporation and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Blueprint Medicines Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Celldex Therapeutics, Inc.